ARMC5 and adrenal gland hyperfunction: Both study groups (BMAHremission, BMAHactive) were well-comparable regarding gender, age at initial diagnosis, degree of hypercortisolism at initial diagnosis (considering UFC and cortisol after 1 mg-DST), ARMC5 mutational status, and side of U-Adx (as shown in Table 1).